Next Article in Journal
Dihydrogen Bonds in Salts of Boron Cluster Anions [BnHn]2− with Protonated Heterocyclic Organic Bases
Next Article in Special Issue
Synthesis, Crystal Structure, and Solubility Analysis of a Famotidine Cocrystal
Previous Article in Journal
Minority Carrier Trap in n-Type 4H–SiC Schottky Barrier Diodes
Previous Article in Special Issue
Elucidation of the Crystal Structures and Dehydration Behaviors of Ondansetron Salts
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Preparation of Theophylline-Benzoic Acid Cocrystal and On-Line Monitoring of Cocrystallization Process in Solution by Raman Spectroscopy

1
State Key Laboratory of Chemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
2
Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin 300072, China
3
Key Laboratory Modern Drug Delivery and High Efficiency in Tianjin University, Tianjin 300072, China
*
Authors to whom correspondence should be addressed.
Crystals 2019, 9(7), 329; https://doi.org/10.3390/cryst9070329
Submission received: 5 June 2019 / Revised: 23 June 2019 / Accepted: 25 June 2019 / Published: 27 June 2019
(This article belongs to the Special Issue Pharmaceutical Crystals)

Abstract

:
Pure theophylline-benzoic acid cocrystal was prepared via slurry and cooling crystallization in solution to overcome the disadvantages of existing preparation methods. The target cocrystal was characterized by powder X-ray diffraction (PXRD), thermalgravimetric analysis (TGA), differential scanning calorimetry (DSC) and Raman spectroscopy. The slurry and cooling cocrystallization process in solution was monitored via on-line Raman spectroscopy. The results obtained from on-line Raman monitoring can exhibit the transformation process from raw materials (theophylline and benzoic acid) to cocrystal and show the cocrystal formation rate. Comparing each transformation process under different conditions in slurry crystallization, we found that suspension density of raw materials and temperature both have an impact on the theophylline-benzoic acid cocrystal formation rate. It could be concluded that the cocrystal formation rate increased with the increase of suspension density of raw materials. Further under the same suspension density, higher temperature will accelerate theophylline-benzoic acid cocrystal formation. Meanwhile, various data from the cocrystallization process in cooling crystallization, including nucleation time, nucleation temperature and suitable cooling ending point can be gained from results of on-line Raman monitoring.

Graphical Abstract

1. Introduction

Active pharmaceutical ingredients (API) can exist in different solid-state forms, such as polymorphs, salts, solvates, amorphous forms and cocrystals [1]. Cocrystal is a new class of pharmaceutical crystal form, which can improve the physicochemical properties of API effectively without affecting their internal structure [2]. Cocrystals are molecular complexes that contain two or more components together in the same crystal lattice, and their structures are based on hydrogen bonds, π-π stacking, van der Waals forces and other non-covalent bonds [3]. In contrast to salts, cocrystal formation can be envisaged for acidic, basic and neutral APIs to open up new opportunities for the pharmaceutical industry [4]. Cocrystal synthesis has been carried out using a variety of methods, such as slow evaporation [5,6], cooling crystallization [7,8], slurry crystallization [9], and mechanochemical synthesis and so on [10].
Among these synthesis methods, cooling and slurry crystallization are widely used in preparation of pharmaceutical cocrystals because they can achieve larger scale and higher yield of target cocrystals compared with other methods [7,8,9]. In recent studies, the research of pharmaceutical cocrystal is mainly focused on how to improve physicochemical properties of APIs and enhance their efficacy. Many articles have been published which are associated with the design, characterization analysis and properties of cocrystals [11,12,13,14,15]. However, the understanding of cocrystals is still far less than that of other solid forms and the understanding of the cocrystallization process in solution remains to be developed. With cooling and slurry crystallization, the cocrystal formation process is convenient to monitor and control by some on-line analysis methods, such as Raman spectroscopy, Fourier transform infrared spectroscopy (FTIR) and focused beam reflectance measurement (FBRM). Raman spectroscopy, as a kind of reliable and effective technique that can detect both solid and liquid phases, is more suitable to monitor cocrystal formation [16,17,18,19].
Theophylline (TP) is a drug for asthma therapy and chronic obstructive pulmonary disease treatment [20]. However, in clinical application, the low water solubility limits its bioavailability. For this reason, new molecular compounds containing theophylline need to be developed to expand its clinical application. Therefore, the synthesis of cocrystal is research focused on improving physicochemical properties of theophylline [21,22,23,24,25,26]. Theophylline has great potential to form cocrystal due to the carbonyl groups and aromatic nitrogen atoms in the structure, which are readily to form hydrogen bonds. Hence, theophylline is a good model molecule to research cocrystal formation and investigate the cocrystallization mechanism. According to the literature, the cocrystals of theophylline have been successfully prepared with several carboxylic acids, such as glutaric acid, oxalic acid, and benzoic acid [10,27,28]. Benzoic acid (BA) occurs naturally in many plants and serves as an intermediate in the biosynthesis of many secondary metabolites [29]. Benzoic acid is a good non-toxic cocrystal coformer because of the carboxyl group in its structure, which can form many kinds of cocrystals with different APIs. The 1:1 theophylline-benzoic acid cocrystal has been reported to be prepared via neat grinding and slow evaporation [27,30]. These two methods are mostly commonly used in cocrystal screening, however are not conducive for robust scaling because of the inherent limitations of the techniques and solution crystallization most widely used to achieve large-scale production of crystals [13,31]. Therefore, solution crystallization need to be explored to prepare pure theophylline-benzoic acid cocrystal.
Our research focuses on preparation and on-line monitoring of the formation process of theophylline-benzoic acid cocrystal. The molecule structure of TP-BA cocrystal at a stoichiometric molar ratio of 1:1 from the Cambridge Crystallographic Data Centre is shown in Figure 1 [27]. In this study, we successfully prepared pure TP‑BA cocrystal via solution crystallization (slurry and cooling crystallization) and characterized the solid phase of the theophylline‑benzoic acid cocrystal by different analysis methods. In our research, we investigated the TP-BA cocrystal formation process in slurry and cooling crystallization by on-line Raman spectroscopy. Furthermore, the influence of suspension density of raw materials (theophylline and benzoic acid) and temperature on cocrystal formation rate in slurry crystallization was demonstrated. Further, the nucleation temperature and suitable cooling ending point in cooling crystallization can be also achieved by on-line Raman monitoring.

2. Materials and Methods

2.1. Materials

Theophylline (Form II) was purchased from Aladdin-Reagent Technology Co. Ltd. (Shanghai, China) and benzoic acid was purchased from Tianjin Guangfu Chemical Reagent Co. (Tianjin, China). Deionized water and analytic grade methanol (Tianjin Kewei Chemical Reagent Co., Tianjin, China) were used in this work. All materials were used without further purification. Table 1 shows mass fraction purity and provenance of the materials.

2.2. Preparation of Theophylline-Benzoic Acid Cocrystal

Theophylline-benzoic acid cocrystal was synthesized by slurry and cooling crystallization in methanol/water mixture (V:V = 1:5). In our pre-experiments, the target cocrystal was synthesized in pure acetonitrile and the ratio of API and coformer used for preparation was 1:5 due to the solubility difference between theophylline and benzoic acid, which resulted in benzoic acid being wasted. The mixed solvents (methanol/water mixture) decreased the solubility difference between TP and BA and modified the raw materials ratio to 1:1 to avoid wasting of coformer.
In the slurry crystallization, TP-BA cocrystal solubility in methanol/water mixture solution (V:V = 1:5) was determined by static method with high-performance liquid chromatography (HPLC), which was 0.087 mol/L at 298.15 K. A total of 5.95 mmol TP and 5.9 5mmol BA was added a 36 mL methanol/water mixture to make a suspension of both TP and BA. Due to the total added materials and cocrystal solubility, the suspension density was 0.078 mol/L TP and 0.078 mol/L BA at 298.15 K. The TP and BA suspension was stirred magnetically in a water bath at 298.15 K for at least 5 h to reach equilibrium. Then the cocrystal product was filtered from the suspension and dried at 313.15 K for 12 h. In the cooling crystallization, 3.5 mmol TP and 3.5 mmol BA were dissolved in 36 ml methanol/water mixture (V:V = 1:5). The solution temperature was kept at 313.15 K for 1 h, and then cooled to 278.15 K with a 9 K/h cooling rate. The TP-BA cocrystal can be formed in the cooling process. The solid product of cooling crystallization was isolated over a filter paper (Whatman 2.5 μm grade, Shanghai, China) using vacuum filtration and dried for 12 h at 313.15 K in an oven. The temperature of the water bath was controlled by a thermostat (XODC-2006, Xianou Laboratory Instrument Works Co., Ltd., Nanjing, China), and the system temperature variation for all the measurements was found to be less than ±0.1 K. The cocrystal products gained from slurry and cooling crystallization were analyzed by powder X-ray diffraction (PXRD, Rigaku, Tokyo, Japan) and high-performance liquid chromatography (HPLC, Agilent Technologies, Inc., Carpinteria, CA, USA) to determine solid phase composition. Then TP-BA cocrystal was characterized by differential scanning calorimetry (DSC, Mettler Toledo, Greifensee, Switzerland), thermogravimetric analysis (TGA, Mettler Toledo, Greifensee, Switzerland) and Raman spectroscopy (Kaiser Raman RXN2, Ann Arbor, MI, USA). Raman spectroscopy was used to monitor the cocrystal formation process during slurry and cooling crystallization.

2.3. Monitoring Cocrystallization Process of Theophylline and Benzoic Acid in Slurry Crystallization

To explore the factors affecting the TP-BA cocrystal formation process in slurry crystallization, we performed four sets of slurry experiments in a methanol/water mixture (V:V = 1:5). The corresponding temperature, initial concentration and suspension density of raw materials are listed in Table 3. The suspension density was calculated from the total concentration and cocrystal solubility at 298.15 K and 313.15 K. Cocrystal solubility at 298.15 K and 313.15 K was determined by static method with HPLC. The ratio of TP and BA in cocrystal products was analyzed using HPLC to confirm TP-BA cocrystal purity. This cocrystallization process was monitored by Raman spectroscopy for 5 h to reach the equilibrium. The whole spectra was obtained at a spectral range of 200–1800 cm−1.

2.4. Analytical Methods

A Raman spectrometer (RXN2, Kaiser Optical systems, Inc., Ann Arbor, MI, USA) was used for both off-line measurement of solid samples and on-line monitoring of cocrystal formation process in slurry and cooling crystallization. In the Raman spectroscopy, the spectral resolution and the excitation wavelength of the laser were 5 cm−1 and 785 nm, respectively.
The PXRD patterns of the TP−BA cocrystal were obtained using a powder diffractometer (D/MAX 2500, Rigaku, Tokyo, Japan) with a Cu Kα radiation (1.54 Å), tube voltage of 40 kV, and current of 100 mA. Data were collected between 2° and 40° in 2θ with steps of 0.05° and a dwelling time of 1 s per step.
Thermal measurements were performed by TGA/DSC (1/500, Mettler Toledo, Greifensee, Switzerland) protected by nitrogen atmosphere. Experimental conditions were followed as pans of 40 μL volume with a heating rate of 10 K/min and a scan range from 298.15 K to 573.15 K.
The ratio of TP and BA in cocrystal products was analyzed by high-performance liquid chromatography (HPLC). The HPLC is equipped with a UV-vis spectrophotometer detector and uses a C18 column (Extend, 5 μm, 4.6 × 250 mm, Agilent Technologies, Inc., Carpinteria, CA, USA) to separate TP and BA. The mobile phase was composed of 60% methanol and 40% water with 0.1% trifluoroacetic acid. The flow was set at 1 mL/min and the sample injection volume was 20 μL. Absorbance was monitored at 250 nm. Data collection and processing were performed using software from Agilent Technologies, Inc., Carpinteria, CA, USA.

3. Results and Discussion

3.1. Solid Phases Characterization of Theophylline-benzoic Acid Cocrystal

The powder X-ray diffraction patterns of TP, BA, physical mixture, solid products obtained in slurry and cooling crystallization, and the calculated data of TP-BA cocrystal from single crystal X-ray data [27] are presented in Figure 2a. The PXRD patterns of the cocrystal products obtained in slurry and cooling crystallization are significantly different from those of TP, BA and physical mixture, but the same as the PXRD pattern calculated by single-crystal X-ray data [27]. In detail, the peaks at 6.10° and 17.58°, which are characteristics peaks of TP, are absent in the PXRD patterns of the cocrystal, as is the characteristic peak of BA at 7.98°. Meanwhile, some new peaks appear at 11.40° and 19.46° in the cocrystal product pattern, which are the same as the PXRD pattern of the calculated data of the TP-BA cocrystal. Therefore, the formation of TP-BA cocrystal can be confirmed by the changes in the PXRD patterns. The ratio of TP and BA in cocrystal products is obtained as 1:1 by HPLC.
The DSC and TGA curves of TP, BA, TP-BA cocrystal and physical mixture are shown in Figure 2. The melting points of theophylline and benzoic acid are 545.5 K and 395.1 K, respectively. In the DSC curve of the TP-BA cocrystal, the first endothermic peak at around 411.1 K is the melting point of cocrystal, which is significantly different from API and coformer. The second peak indicates the cocrystal decomposing at 455.3 K. Around this temperature, benzoic acid breaks away from the structure of the TP-BA cocrystal, and theophylline recrystallizes to the solid phase. In the TGA curve of cocrystal, at 455.3 K solid weight begins decreasing and the total weightlessness is about 40%, which is equal to the mass fraction of BA in cocrystal. The last peak in DSC curve of the TP-BA cocrystal at 545.5 K is the melting point of the remaining theophylline. Moreover, the DSC curve of the physical mixture has four endothermic peaks. The peak at 384.5 K indicates that solid theophylline and solid benzoic acid form the TP-BA cocrystal at this temperature and the next peak at 411.1 K is the melting point of the cocrystal, which corresponds with the curve of pure cocrystal. Further, the peaks at 455.3 K and 545.5 K represent the decomposition of BA from the cocrystal and the melting point of the remaining TP, respectively, which are as same as those in the DSC curve of cocrystal.
Figure 2d shows the Raman spectra of the target cocrystal, physical mixture, TP and BA. It is obviously that the spectra of the cocrystal is different from those of TP and BA. For instance, TP and BA have the characteristic peaks at 1688, 1323, 1171 and 918 cm−1, while the characteristic peaks of the cocrystal are at 1678, 1331, 1161 and 925 cm−1. The difference between the Raman spectra of the cocrystal and raw materials can be used to identify TP-BA cocrystal formation and monitor the cocrystallization process in solution.

3.2. Crystal Structure Analysis of TP-BA Cocrystal

The crystallographic data of the TP-BA cocrystal is obtained from Cambridge Crystallographic Data Centre (CCDC) [27] and the crystal structure is shown in Figure 3. Each TP molecule is connected to one BA molecule via two hydrogen bonds to form a dimer. One hydrogen bond is formed between the acidic nitrogen atom on the imidazole ring from the TP molecule and the carboxyl oxygen atom from the BA molecule. The other is formed between the carbonyl group from the TP molecule and the carboxyl group of the BA molecule. The dimers of TP-BA molecules are arranged parallel to the b-c plane, then form stacks along the a-axis. The space group of the TP-BA cocrystal is monoclinic, P21/n and has cell parameters a = 6.98690 (17) Å, b =25.10944 (84) Å, c = 8.60685 (30) Å, β = 108.5597 (18), and V = 1431.431 (78) Å3. From the TP-BA cocrystal structure, two hydrogen bonds’ interaction results in changes in the stretching vibrations of the bonds in TP and BA molecules’ structures, which can cause peak shifts in the Raman spectra (Figure 4). For example, the peak at 1688 cm−1 is observed in both Raman spectra of TP and the physical mixture, while there is no peak at a similar position in the Raman spectra of BA. It indicates that this peak should be caused by stretching vibrations of the N-C=O bond in TP molecule. The hydrogen bond, N-C=O·H-O, formation, causes this peak to shift from 1688 cm−1 to 1678 cm−1. Similarly, in the spectra of TP and physical mixture we can see a peak at 918 cm−1, which represents N-H on the imidazole ring. After forming a hydrogen bond, N-H·O=C, this peak shifts to 925 cm−1. Therefore, during the cocrystallization process, the Raman spectra of the solution would change resulting from hydrogen bonds’ interaction between TP and BA molecules, which can be used to monitor the TP-BA cocrystal formation process.

3.3. On-Line Monitoring of TP-BA Cocrystal Formation Process in Slurry Crystallization

The Raman spectra at 200–1800 cm−1 obtained from slurry crystallization at 298.15 K is shown in Figure 4. In this figure, the shifts of the Raman spectra within operating time can be observed. The main shifts ranges are at (1) 1678–1688 cm−1, (2) 1323–1331 cm−1, (3) 1161–1171 cm−1, and (4) 918–925 cm−1, respectively, and are marked with circles in Figure 4, which are corresponding with the off-line Raman spectra of the solid phase of TP, BA and cocrystal. That demonstrates that on-line Raman spectroscopy can be used to monitor the TP-BA cocrystal formation process in slurry crystallization.
Figure 5a presents the Raman spectra of the range of 1640–1720 cm−1 obtained from slurry crystallization at 298.15 K. A main peak shift from 1688 cm−1 to 1678 cm−1 can be observed in the spectra. The solid-state Raman spectra of TP, BA and cocrystal were analyzed in Section 3.1. The characteristic peak at 1688 cm−1 can represent raw materials in the suspension, while the peak at the 1678 cm−1 could represent the TP-BA cocrystal existing in the slurry. Further, the peak intensity in the Raman spectra is positively related with the concentration of the compounds. The appearance of the characteristic peak, which represents the cocrystal, could demonstrate TP-BA cocrystal nucleation, and the decrease of the characteristic peak intensity of drug and coformer indicates raw material consumption, which is caused by the transformation from raw materials to cocrystal. Therefore, the target cocrystal formation can be identified by monitoring the characteristic peak intensity of the TP-BA cocrystal and raw materials. At the beginning of slurry crystallization only the peak at 1688 cm−1 could be seen from the spectra. As the cocrystallization process proceeds, the peak at 1678 cm−1 appears and the intensity starts to increase, which proves the TP-BA cocrystal formation. The intensity at 1630 cm−1 as the baseline is used to compare the intensity of two peaks, 1678 and 1688 cm−1. The difference between the intensity of characteristics peaks and the baseline is named the “relative peak intensity”. The changes of the relative peak intensity of 1688 cm−1 and 1678 cm−1 are shown in Figure 5b. We can see that the relative intensity of 1678 cm−1 increases from −250 to 250 over 44 min and then maintains a stable level. Meanwhile, the relative peak intensity of 1688 cm−1 decreases from 1500 to 240 during the same period. The results indicate that at this condition the transformation from raw materials to cocrystal finishes at 44 min, and can help us to improve the design of cocrystallization experiments and save more resources and time.
The spectra of 1270–1360 cm−1 can be observed in Supplementary Materials Figure S1a. During the cocrystallization process, the intensity of the peak at 1323 cm−1 keeps decreasing, while the intensity of the peak at 1331 cm−1 gradually increases within the operating time. We choose the intensity of 1306 cm−1 as the baseline for the characteristic peaks of 1323 and 1331 cm−1. The relative intensity of these two peaks is calculated by the above method and presented in Supplementary Figure S1b. The relative peak intensity of 1323 cm−1 decreases from 2000 to 500, while that of the peak at 1331cm−1 rises from 1200 to 1750 over a period of about 44 min. Further, the time of transformation from raw materials to cocrystal obtained from the relative intensity change is the same as for the above analysis.
Moreover, two peak shifts can be seen at the range of 1120–1200 cm−1 and 890–940 cm−1, respectively. One peak at 1171 cm−1 shifts to 1161 cm−1 (Supplementary Figure S2a) and another moves from 918 to 925 cm−1 (Supplementary Figure S3a). When the slurry crystallization begins, we can only see the peak at 1171 and 918 cm−1. As the cocrystal formation proceeds, the peaks at 1161 and 925 cm−1 appear. The intensities of 1140 and 900 cm−1 are used as the baseline. In the Supplementary Figure S2b, the relative intensity of the peak at 1171 cm−1 reduces from 1300 to 350 and the relative peak intensity at 1161 cm−1 increases from 620 to 1050 over a period of 44 min. Similarly, the relative intensity of the peak at 918 cm−1 reduces from 1400 to 300, however the intensity of the peak at 925 cm−1 increases from 700 to 1250 at the same time (Supplementary Figure S3b).
From the above information obtained from relative intensity change of four couples of characteristics peaks, we know the total time taken for TP-BA cocrystal formation in slurry crystallization under this condition. Therefore, Raman spectroscopy can be used as a reliable and suitable technique to monitor the formation of TP-BA cocrystal and help us to design cocrystallization experiments.

3.4. Influence of Suspension Density of Raw Materials and Temperature on Theophylline-benzoic Acid Cocrystal Formation in Slurry Crystallization

To explore the factors affecting TP-BA cocrystal formation process in slurry crystallization, on-line monitoring of the cocrystallization process in solution by Raman spectroscopy was carried out in a methanol/water mixture under different temperatures and suspension densities of raw materials. Besides the above slurry experiment, we added another three sets of experiments at 298.15 K and 313.15 K with different suspension densities of raw materials. The corresponding conditions of the four sets of experiments are shown in Table 3.
The peak at 1688 cm−1 was chosen as the characterization peak of raw materials in suspension and the peak at 1678 cm−1 was selected as the characterization peak of cocrystal. The relative peak intensity is presented in Figure 6 (the baseline is the same as above). In Figure 6, the total time taken for cocrystal formation in each experiment under different conditions can be obtained and the formation time was 44 min, 57 min, 22 min, and 43 min respectively.
Comparing the cocrystal formation time under different conditions in slurry crystallization, we found that the suspension density of raw materials and the temperature both have impact on the transformation from raw materials to cocrystal. From the results of exp 1 and 2 (Table 3, Figure 6), the cocrystal formation time of exp 1 is obviously shorter than that of exp 2, while the initial concentration of raw materials in exp 1 is higher than exp 2. The results show that when the initial concentration of raw materials is higher, TP-BA cocrystal formation is faster. The initial concentration directly affects the suspension density of raw materials, and higher suspension density can improve the collision probability of raw material particles in slurry crystallization to expedite cocrystal formation. Meanwhile, the total contact surface area between the API and coformer molecules in suspension can be increased as the suspension density becomes higher, and this can also improve cocrystal formation rate. Therefore, the suspension density of raw materials can affect cocrystal formation and the cocrystal formation rate would increase as the suspension density of raw materials increases. The same results can be achieved by comparing the transformation time from raw materials to cocrystal in exp 3 and 4. The lower formation time in exp 3 indicates higher suspension density in exp 3 (0.078 M) can achieve a higher rate of transformation from raw materials to TP-BA cocrystal than in exp 4 (suspension density is 0.042 M) when reaction temperature is same.
Comparing Raman spectra of exp 1 and 3, under the same suspension density condition, TP-BA cocrystal formation is faster in exp 3 when the temperature is higher than that of exp 1. This is mainly because higher temperature will facilitate the raw materials to reach the activated state with less time, and can thus shorten the formation time. The spectra of on-line monitoring of exp 2 and 4 show the same results. With the same suspension density of raw materials exp 4 (313.15 K) has a higher rate of TP-BA cocrystal formation than exp 2 (298.15 K), which also indicates temperature has an impact on TP-BA cocrystal formation under the same suspension density condition.

3.5. On-Line Monitoring of TP-BA Cocrystal Formation Process in Cooling Crystallization

Similar to the slurry experiments, Raman spectroscopy can be also used to monitor the cooling crystallization process of TP-BA cocrystal. In cooling crystallization, the TP-BA cocrystal was prepared in a methanol/water mixture (V:V = 1:5). The Raman spectra obtained from cooling crystallization, which has the same peak shifts as in slurry experiments, can provide various data of the cocrystallization process, including nucleation time, nucleation temperature and suitable cooling ending point.
Two couples of peaks at 1678/1688 cm−1 and 918/925 cm−1 are regarded as the characteristics peaks to investigate the cocrystal formation process in cooling crystallization. The corresponding relative peak intensity is calculated by the above method and shown in Figure 7. It can be seen from Figure 7 that the peak intensities of 1678 and 925 cm−1, which represent the TP-BA cocrystal, start to increase at 170 min, and those of 1688 and 918 cm−1, which represent the raw materials, begin decreasing at the same time. This means that at 170 min in the cooling process cocrystal nucleation occurs. Further, the nucleation temperature of TP-BA cocrystal can be calculated from the combined nucleation time and cooling rate, which is at 296.65 K. In theory, during the cooling process the amount of TP-BA cocrystal should keep increasing because the cocrystal solubility decreases continuously as temperature decreases. However, from the Raman spectra of the on-line monitoring of cooling crystallization (Figure 7), the relative peak intensity that represents the cocrystal shows no significant increase and stays at an approximately stable level after 250 min of the cooling process. That is because when cocrystal solubility decreases to a relatively low level, the yield cannot be increased significantly by further cooling. The corresponding temperature is the ending point of the cooling process. In the TP-BA cooling crystallization process, the ending temperature obtained from the Raman spectra of on-line monitoring is 284.65 K. Hence, on-line monitoring in cooling crystallization by Raman spectroscopy can be used to monitor cocrystal formation and to obtain information about the cocrystal nucleation temperature and ending temperature in cooling crystallization.

4. Conclusions

In this work, the theophylline-benzoic acid cocrystal was prepared in solution via slurry and cooling crystallization. The solution synthesis of TP-BA cocrystal overcomes the disadvantages of existing preparation methods and can be used to produce large scale and high purity TP-BA cocrystal. The TP-BA cocrystal was characterized by PXRD, DSC, TGA and Raman spectroscopy. The cocrystallization process of TP and BA in solution was monitored by on-line Raman spectroscopy (both slurry and cooling crystallization). The change of peak intensity in the cocrystal formation process can be observed easily from the Raman spectra. The factors affecting the cocrystal formation rate in slurry crystallization were also explored. The results of Raman spectra show that suspension density of drug and coformer, and temperature, both have an impact on TP-BA cocrystal formation. The cocrystallization process will become faster as the suspension density increases. When suspension density of the raw materials is the same, a higher temperature can improve the TP-BA cocrystal formation rate. Temperature and suspension density of raw materials both have a positive correlation with the TP-BA cocrystal formation rate. Furthermore, nucleation temperature and cooling ending point can be obtained by on-line monitoring of the cocrystal formation process in cooling crystallization.

Supplementary Materials

The following are available online at https://www.mdpi.com/2073-4352/9/7/329/s1, Figure S1: (a) The variation of Raman spectra at 1270–1360 cm−1; (b) The change of relative peak intensity of 1323/133 1 cm 1 in TP BA cocrystal formation in slurry crystallization at 298.15 K. Figure S2: (a) The variation of Raman spectra at 1120–1200 cm−1; (b) The change of relative peak intensity of 1161/1171 cm−1 in TP-BA cocrystal formation in slurry crystallization at 298.15 K. Figure S3: (a) The variation of Raman spectra at 890–940 cm−1; (b) The change of relative peak intensity of 918/925 cm−1 in TP-BA cocrystal formation in slurry crystallization at 298.15 K. Figure S4: HPLC chromatograms of slurry crystallization products in Table 3: exp 1 (a); exp 2 (b); exp 3 (c); exp 4 (d) and cooling crystallization product (e).Table S1: Information about Raman spectra in the range of 1640–1720 cm−1 in Figure 5a. Table S2: Information about Raman spectra in the range of 1270–1360 cm−1 in Figure S1a. Table S3: Information about Raman spectra in the range of 1120–1200 cm−1 in Figure S2a. Table S4: Information about Raman spectra in the range of 890–940 cm−1 in Figure S3a.

Author Contributions

Conceptualization, Y.H., L.Z. and Q.Y.; Formal analysis, W.Y., Y.Y. and C.W.; Funding acquisition, L.Z. and Q.Y.; Investigation, Y.H. and Q.Y.; Methodology, Y.H. and Q.Y.; Project administration, Y.H. and Q.Y.; Supervision, L.Z. and Q.Y.; Writing—original draft, Y.H.; Writing—review & editing, Y.H., Y.L., Z.Z. and X.Z.

Funding

The support from National Engineering Research Center for Industrial Crystallization Technology (NERCICT) is acknowledged. This work was supported by Major National Scientific Instrument Development Project of China (No. 21527812) and Tianjin Municipal Natural Science Foundation (No. 16JCZDJC32700).

Conflicts of Interest

The authors declare no competing financial interest.

References

  1. Byrn, S.R.; Zografi, G.; Chen, X. Accelerating proof of concept for small molecule drugs using solid-state chemistry. J. Pharm. Sci. 2010, 99, 3665–3675. [Google Scholar] [CrossRef] [PubMed]
  2. Schultheiss, N.; Newman, A. Pharmaceutical cocrystals and their physicochemical properties. Cryst. Growth Des. 2009, 9, 2950–2967. [Google Scholar] [CrossRef] [PubMed]
  3. Aakeröy, C.B.; Salmon, D.J. Building co-crystals with molecular sense and supramolecular sensibility. CrystEngComm 2005, 7, 439–448. [Google Scholar] [CrossRef]
  4. Rodríguez-Hornedo, N. Cocrystals: Molecular design of pharmaceutical materials. Mol. Pharm. 2007, 4, 299–300. [Google Scholar] [CrossRef]
  5. Liao, X.M.; Gautam, M.; Grill, A.; Zhu, H.J.J. Effect of position isomerism on the formation and physicochemical properties of pharmaceutical co-crystals. J. Pharm. Sci. 2010, 99, 246–254. [Google Scholar] [CrossRef] [PubMed]
  6. Thanigaiman, K.; Khalib, N.C.; Temel, E.; Arshad, S.; Razak, I.A. New supramolecular cocrystal of 2-amino-5-chloropyridine with 3-methylbenzoic acids: Syntheses, structural characterization, hirshfeld surfaces and quantum chemical investigations. J. Mol. Struct. 2015, 1099, 246–256. [Google Scholar] [CrossRef]
  7. Hickey, M.B.; Peterson, M.L.; Scoppettuolo, L.A.; Morrisette, S.L.; Vetter, A.; Guzmán, H.; Remenar, J.F.; Zhang, Z.; Tawa, M.D.; Haley, S.; et al. Performance comparison of a co-crystal of carbamazepine with marketed product. Eur. J. Pharm. Biopharm. 2007, 67, 112–119. [Google Scholar] [CrossRef]
  8. Remenar, J.F.; Perterson, M.L.; Stephens, P.W.; Zhang, Z.; Zimenkov, Y.; Hickey, M.B. Celecoxib: Nicotinamide dissociation: Using excipients to capture the cocrystal’s potential. Mol. Pharm. 2007, 4, 386–400. [Google Scholar] [CrossRef]
  9. Zhang, S.; Rasmuson, Å.C. The theophylline–oxalic acid co-crystal system: Solid phases, thermodynamics and crystallization. CrystEngComm 2012, 14, 4644–4655. [Google Scholar] [CrossRef]
  10. Kulla, H.; Greiser, S.; Benemann, S.; Rademann, K.; Emmerling, F. In situ investigation of a self-accelerated cocrystal formation by grinding pyrazinamide with oxalic acid. Molecules 2016, 21, 917. [Google Scholar] [CrossRef]
  11. Basavoju, S.; Boström, D.; Velaga, S.P. Indomethacin-saccharin cocrystal: Design, synthesis and preliminary pharmaceutical characterization. Pharm. Res. 2008, 25, 530–541. [Google Scholar] [CrossRef]
  12. Chieng, N.; Rades, T.; Aaltonen, J. An overview of recent studies on the analysis of pharmaceutical polymorphs. J. Pharm. Biomed. Anal. 2011, 55, 618–644. [Google Scholar] [CrossRef]
  13. Holaň, J.; Štěpánek, F.; Billot, P.; Ridvan, L. The construction, prediction and measurement of co-crystal ternary phase diagrams as a tool for solvent selection. Eur. J. Pharm. Sci. 2014, 63, 124–131. [Google Scholar] [CrossRef]
  14. Ueto, T.; Takata, N.; Muroyama, N.; Nedu, A.; Sasaki, A.; Tanida, S.; Terada, K. Polymorphs and a hydrate of furosemide-nicotinamide 1:1 cocrystal. Cryst. Growth Des. 2012, 12, 485–494. [Google Scholar] [CrossRef]
  15. Friščić, T.; Jones, W. Recent Advances in Understanding the Mechanism of Cocrystal Formation via Grinding. Cryst. Growth Des. 2009, 9, 1621–1637. [Google Scholar] [CrossRef]
  16. Soares, F.L.F.; Carneiro, R.L. Green Synthesis of Ibuprofen−Nicotinamide Cocrystals and In-Line Evaluation by Raman Spectroscopy. Cryst. Growth Des. 2013, 13, 1510–1517. [Google Scholar] [CrossRef]
  17. Lee, K.S.; Kim, K.J.; Ulrich, J. In Situ Monitoring of Cocrystallization of Salicylic Acid−4,4′-Dipyridyl in Solution Using Raman Spectroscopy. Cryst. Growth Des. 2014, 14, 2893–2899. [Google Scholar] [CrossRef]
  18. Tong, Y.; Zhang, P.; Dang, L.; Wei, H. Monitoring of cocrystallization of ethenzamide saccharin: Insight into kineticprocess by in situ Raman spectroscopy. Chem. Eng. Res. Des. 2016, 109, 249–257. [Google Scholar] [CrossRef]
  19. Kojima, T.; Tsutsumi, S.; Yamamoto, K.; Ikeda, Y.; Moriwaki, T. High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate. Int. J. Pharm. 2010, 399, 52–59. [Google Scholar] [CrossRef]
  20. Trask, A.V.; Motherwell, W.D.S.; Jones, W. Physical stability enhancement of theophylline via cocrystallization. Int. J. Pharm. 2006, 320, 114–123. [Google Scholar] [CrossRef]
  21. Abourahma, H.; Urban, J.M.; Morozowich, N.; Chan, B. Examining the robustness of a theophylline cocrystal during grinding with additives. CrystEngComm 2014, 14, 6163–6169. [Google Scholar] [CrossRef]
  22. Alhalaweh, A.; Kaialy, W.; Buckton, G.; Gill, H.; Nokhodchi, A.; Velaga, S.P. Theophylline Cocrystals Prepared by Spray Drying: Physicochemical Properties and Aerosolization Performance. AAPS PharmSciTech. 2013, 14, 265–276. [Google Scholar] [CrossRef] [Green Version]
  23. Fulias, A.; Soica, C.; Ledeti, I.; Vlase, T.; Vlase, G.; Suta, L.M.; Belu, I. Characterization of Pharmaceutical Acetylsalicylic Acid-theophylline Cocrystal Obtained by Slurry Method Under Microwave Irradiation. Rev. Chim. 2014, 65, 1281–1284. [Google Scholar]
  24. Lin, H.L.; Hsu, P.C.; Lin, S.Y. Theophylline-citric acid co-crystals easily induced by DSC-FTIR microspectroscopy or different storage conditions. Asian J. Pharm. Sci. 2013, 8, 18–26. [Google Scholar] [CrossRef]
  25. Lu, J.; Rohani, S. Preparation and Characterization of Theophylline-Nicotinamide Cocrystal. Org. Process Res. Dev. 2009, 13, 1269–1275. [Google Scholar] [CrossRef]
  26. Zhang, S.; Chen, H.; Rasmuson, Å.C. Thermodynamics and crystallization of a theophylline-salicylic acid cocrystal. CrystEngComm 2015, 17, 4125–4135. [Google Scholar] [CrossRef]
  27. Heiden, S.; Tröbs, L.; Wenzel, K.J.; Emmerling, F. Mechanochemical synthesis and structural characterisation of a theophylline-benzoic acid cocrystal (1:1). CrystEngComm 2012, 14, 5128–5129. [Google Scholar] [CrossRef]
  28. Zhang, S.; Rasmuson, Å.C. Thermodynamics and Crystallization of the Theophylline-Glutaric Acid Cocrystal. Cryst. Growth Des. 2013, 13, 1153–1161. [Google Scholar] [CrossRef]
  29. Widhalm, J.R.; Dudareva, N. A familiar ring to it: Biosynthesis of plant benzoic acids. Mol. Plant. 2015, 8, 83–97. [Google Scholar] [CrossRef]
  30. Childs, S.L.; Stahly, G.P.; Park, A. The Salt-Cocrystal Continuum: The Influence of Crystal Structure on Ionization State. Mol. Pharm. 2007, 4, 323–338. [Google Scholar] [CrossRef]
  31. Sheikh, A.Y.; Rahim, S.A.; Hammond, R.B.; Roberts, K.J. Scalable solution cocrystallization: Case of carbamazepine-nicotinamide I. CrystEngComm 2009, 11, 501–509. [Google Scholar] [CrossRef]
Figure 1. The molecules of theophylline‑benzoic acid (TP‑BA) cocrystal at a stoichiometric molar ratio of 1:1 (grey atoms: C; red atoms: O; blue atoms: N; white atoms: H).
Figure 1. The molecules of theophylline‑benzoic acid (TP‑BA) cocrystal at a stoichiometric molar ratio of 1:1 (grey atoms: C; red atoms: O; blue atoms: N; white atoms: H).
Crystals 09 00329 g001
Figure 2. The solid characterization spectra of TP, BA, physical mixture and TP-BA cocrystal: (a) powder X-ray diffraction (PXRD); (b) differential scanning calorimetry (DSC); (c) thermogravimetric analysis (TGA); (d) Raman spectroscopy.
Figure 2. The solid characterization spectra of TP, BA, physical mixture and TP-BA cocrystal: (a) powder X-ray diffraction (PXRD); (b) differential scanning calorimetry (DSC); (c) thermogravimetric analysis (TGA); (d) Raman spectroscopy.
Crystals 09 00329 g002
Figure 3. The crystal structure of the TP-BA cocrystal (grey color: C; red color: O; blue color: N; white color: H).
Figure 3. The crystal structure of the TP-BA cocrystal (grey color: C; red color: O; blue color: N; white color: H).
Crystals 09 00329 g003
Figure 4. The variation of the Raman spectra of TP-BA cocrystal formation in slurry crystallization. The time intervals of the Raman spectra are listed in Table 2.
Figure 4. The variation of the Raman spectra of TP-BA cocrystal formation in slurry crystallization. The time intervals of the Raman spectra are listed in Table 2.
Crystals 09 00329 g004
Figure 5. (a) The variation of Raman spectra at 1640–1720 cm−1; (b) The change of relative peak intensity of 1678/1688 cm−1 in TP-BA cocrystal formation in slurry crystallization at 298.15 K. The information about the time interval of the Raman spectra are listed in Table S1.
Figure 5. (a) The variation of Raman spectra at 1640–1720 cm−1; (b) The change of relative peak intensity of 1678/1688 cm−1 in TP-BA cocrystal formation in slurry crystallization at 298.15 K. The information about the time interval of the Raman spectra are listed in Table S1.
Crystals 09 00329 g005
Figure 6. The relative peak intensity during TP-BA cocrystal formation in slurry crystallization: (a) exp 1; (b) exp 2; (c) exp 3; (d) exp 4.
Figure 6. The relative peak intensity during TP-BA cocrystal formation in slurry crystallization: (a) exp 1; (b) exp 2; (c) exp 3; (d) exp 4.
Crystals 09 00329 g006
Figure 7. The relative peak intensity during TP-BA cocrystal formation in cooling crystallization: (a) 1678/1688 cm−1; (b) 918/925 cm−1.
Figure 7. The relative peak intensity during TP-BA cocrystal formation in cooling crystallization: (a) 1678/1688 cm−1; (b) 918/925 cm−1.
Crystals 09 00329 g007
Table 1. Description of materials used in this paper.
Table 1. Description of materials used in this paper.
ChemicalSourceMass Fraction PurityPurification Method
TheophyllineAladdin-Reagent Technology Co. Ltd. (Shanghai, China)>0.990GCa
Benzoic acidTianjin Guangfu Chemical Reagent Co. (Tianjin, China)>0.990GCa
Deionized waterTianjin Kewei Chemical Co. Ltd. (Tianjin, China)>0.995GCa
MethanolTianjin Kewei Chemical Co. Ltd. (Tianjin, China)>0.995GCa
GCa: Gas−liquid chromatography.
Table 2. The time intervals of the Raman spectra shown in Figure 4.
Table 2. The time intervals of the Raman spectra shown in Figure 4.
Total Spectra NumberTotal Recording Time/minTime Point of First Spectra/minTime Interval/min
2010055
Table 3. Temperature, initial concentration, suspension density of raw materials and formation time in TP-BA cocrystal formation process in slurry crystallization.
Table 3. Temperature, initial concentration, suspension density of raw materials and formation time in TP-BA cocrystal formation process in slurry crystallization.
Temperature/KInitial Concentration of TP/MInitial Concentration of BA/MSuspension Density of TP/MSuspension Density of BA/MRatio of TP and BA in Cocrystal aFormation Time/min
exp 1298.150.1650.1650.0780.0781:144
exp 2298.150.1300.1300.0420.0421:157
exp 3313.150.2920.2920.0780.0781:122
exp 4313.150.2560.2560.0420.0421:143
a High-performance liquid chromatography (HPLC) chromatograms of product of each set are shown in Supplementary Figure S4.

Share and Cite

MDPI and ACS Style

Huang, Y.; Zhou, L.; Yang, W.; Li, Y.; Yang, Y.; Zhang, Z.; Wang, C.; Zhang, X.; Yin, Q. Preparation of Theophylline-Benzoic Acid Cocrystal and On-Line Monitoring of Cocrystallization Process in Solution by Raman Spectroscopy. Crystals 2019, 9, 329. https://doi.org/10.3390/cryst9070329

AMA Style

Huang Y, Zhou L, Yang W, Li Y, Yang Y, Zhang Z, Wang C, Zhang X, Yin Q. Preparation of Theophylline-Benzoic Acid Cocrystal and On-Line Monitoring of Cocrystallization Process in Solution by Raman Spectroscopy. Crystals. 2019; 9(7):329. https://doi.org/10.3390/cryst9070329

Chicago/Turabian Style

Huang, Yaohui, Ling Zhou, Wenchao Yang, Yang Li, Yongfan Yang, Zaixiang Zhang, Chang Wang, Xia Zhang, and Qiuxiang Yin. 2019. "Preparation of Theophylline-Benzoic Acid Cocrystal and On-Line Monitoring of Cocrystallization Process in Solution by Raman Spectroscopy" Crystals 9, no. 7: 329. https://doi.org/10.3390/cryst9070329

APA Style

Huang, Y., Zhou, L., Yang, W., Li, Y., Yang, Y., Zhang, Z., Wang, C., Zhang, X., & Yin, Q. (2019). Preparation of Theophylline-Benzoic Acid Cocrystal and On-Line Monitoring of Cocrystallization Process in Solution by Raman Spectroscopy. Crystals, 9(7), 329. https://doi.org/10.3390/cryst9070329

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop